Colorectal cancer was reported in: 183 of 140,758 GLP1 users 247 of 140,692 aspirin users Among all participants, GLP-1 drugs reduced the risk of colorectal cancer by 36% compared to aspirin
Based on this information, some recommendations for GLP-1 users should focus on disbursing meals throughout the day with the lowest calories at dinnertime
Marys and Belmont in West Virginia
Although health insurance companies tend to cover GLP-1 agonists as a treatment for Type 2 diabetes, coverage for weight loss is less common
Some individuals may experience improved self-esteem and mood due to weight loss
FLORA LICHTMAN: I mean, on the other hand, were seeing some people eating way too little on these drugs and developing nutritional deficiencies